#United States #St. Louis #Healthcare Access #Brado AI #ProviderIQ

Brado AI's Strategic Acquisition of ProviderIQ

In a significant move to enhance healthcare access, Brado AI announced the acquisition of ProviderIQ from Hatchleaf. This strategic acquisition aims to elevate Brado AI's Conversational Engagement Platform (CEP) by integrating advanced precision routing capabilities that address the complexities of modern healthcare delivery.

Healthcare systems are increasingly challenged by the demand to match patient needs with the capacity of available providers. Traditional routing methods often fall short, relying on static directories and oversimplified decision-making processes that fail to reflect the nuanced realities of specialized patient care. Understanding this gap, ProviderIQ offers a data-driven approach that captures clinical context, provider practice patterns, and real-world operational workflows, ensuring that patient-provider matching is both precise and effective.

Co-developed by healthcare professionals Dan Cokely and Dr. Arun Rai, a distinguished urologist affiliated with Johns Hopkins, ProviderIQ is designed based on real-world encounter data. This means that it can more accurately align patients with the most suitable providers and care pathways tailored to specific needs.

Andy Parham, the CEO of Brado AI, emphasized the importance of precision in healthcare access. He stated, "Health systems don't just need more access; they need more precision in how patients are matched to care." With the integration of ProviderIQ into the CEP, Brado AI is uniquely positioned to enhance this precision, leveraging data and clinical insights to better synchronize patient demand and provider supply.

The effectiveness of ProviderIQ has already been demonstrated through its pilot program at Northwell Health, which successfully navigated the complexities of a large provider network. Noteworthy outcomes from this pilot included a dramatic increase in provider match specificity from less than 50% to over 85%, a reduction in time to appointment from 45 days to just 22 days, and a decrease in time to intervention from 74 days to under 30 days.

Now, with ProviderIQ fully integrated into its CEP, Brado AI is set to refine its capabilities, enabling healthcare systems to improve their access performance while simultaneously optimizing the utilization of their constrained resources. This acquisition not only strengthens Brado AI's platform but also enhances the overall experience for patients and healthcare teams alike.

As part of this acquisition, Brado AI has committed to ongoing collaboration with Hatchleaf's founders—Dr. Arun Rai, Dan Cokely, and Nick Mitilenes—to continue advancing the development of precision routing capabilities.

Mitilenes expressed enthusiasm about the future of ProviderIQ under Brado's stewardship, stating, "We are proud of what we built with ProviderIQ and excited to see Brado scale its impact through the Conversational Engagement Platform." This partnership allows Hatchleaf to concentrate on advancing precision therapy navigation, while Brado AI expands the influence and application of their platform in the broader healthcare landscape.

The acquisition of ProviderIQ underlines Brado AI’s dedication to extending the reach and impact of health systems. As care delivery becomes increasingly complex, the ability to translate patient intent into precise, aligned access becomes essential, representing a critical advancement in healthcare technology.

About Brado AI

Brado AI specializes in delivering a Conversational Engagement Platform tailored for healthcare organizations. It helps align patient demand with available resources through AI-driven engagement, triage, and comprehensive routing solutions, ultimately improving access rates, patient retention, and overall resource allocation.

For further inquiries about Brado AI and its services, you can contact:

• - Media Contact: Kim Bowers
• - Position: Chief Operating Officer
• - Email: [email protected]

Stay tuned for more updates as Brado AI continues to innovate within the healthcare sector, making strides towards improved access and better patient outcomes.